Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,894 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,867 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00052169 | Therapy With Docetaxel and ZD1839 for Patients Who Have Advanced Breast Cancer | completed | Phase 2 | 33 | NSABP Foundation IncNETWORK | 1 | Dec 18, 2007 | clinicaltrials |
| NCT00319618 | Combination Weekly Taxotere™ With Iressa™ /Placebo in Metastatic Breast Cancer | completed | Phase 2 | 66 | AstraZenecaINDUSTRY | 1 | Dec 18, 2007 | clinicaltrials |
| NCT00194740 |
| Taxotere Plus Weekly Navelbine and G-CSF: A Study in Stage IV Breast Cancer |
| completed |
| Phase 2 |
| 48 |
| University of WashingtonOTHER |
| 1 |
| Dec 6, 2007 |
| clinicaltrials |
| NCT00102219 | A Study of Pemetrexed Plus Doxorubicin Given to Patients With Advanced Breast Cancer | completed | Phase 2 | 77 | Eli Lilly and CompanyINDUSTRY | 7 | Nov 30, 2007 | clinicaltrials |
| NCT00063102 | A Study of ABT-751 in Patients With Recurrent Breast Cancer After Taxane (Taxol or Taxotere) Therapy. | completed | Phase 2 | 40 | AbbottINDUSTRY | 1 | Nov 29, 2007 | clinicaltrials |
| NCT00145743 | Diagnostics and Therapy of Disease-Related Quality of Life of Patients With Breast Cancer | completed | Phase 1 / Phase 2 | 200 | Tumor Center RegensburgOTHER | 1 | Nov 27, 2007 | clinicaltrials |
| NCT00192101 | Gemcitabine Plus Cisplatin Single Dose Versus Split Dose in the Treatment of Patients With Locally Advanced or Metastatic Breast Cancer After Failure of Anthracyclines and/or Taxanes | completed | Phase 2 | 100 | Eli Lilly and CompanyINDUSTRY | 1 | Nov 20, 2007 | clinicaltrials |
| NCT00215748 | Reduced Dexamethasone Pre-Medication Dose in Elderly Patients Receiving Weekly Docetaxel | terminated | Phase 2 | 40 | Geriatric Oncology ConsortiumOTHER | 1 | Nov 16, 2007 | clinicaltrials |
| NCT00194766 | Continuous Temozolomide in Patients With Advanced or Metastatic Soft Tissue Sarcoma or Metastatic Breast Cancer | completed | Phase 2 | 35 | University of WashingtonOTHER | 1 | Nov 14, 2007 | clinicaltrials |
| NCT00555516 | A Pilot Study to Evaluate the Safety and Activities of EW02 in Reducing Neutropenia Caused by Chemotherapy | unknown | Phase 1 / Phase 2 | 60 | Tri-Service General Hospital (TSGH)OTHER | 1 | Nov 8, 2007 | clinicaltrials |
| NCT00378638 | Dose-Dense Chemotherapy Plus Bevacizumab in High Risk Lymph Node Positive Breast Cancer: A Pilot Study | unknown | Phase 2 | 30 | Chap, Linnea I., M.D.INDIV | 1 | Oct 24, 2007 | clinicaltrials |
| NCT00543829 | German Preoperative Adriamycin Docetaxel Study | completed | Phase 2 | 250 | GBG Forschungs GmbHOTHER | 0 | Oct 17, 2007 | clinicaltrials |
| NCT00191373 | A Trial for HER2 Positive Breast Cancer Patients With Metastatic Disease | completed | Phase 2 | 66 | Eli Lilly and CompanyINDUSTRY | 1 | Sep 12, 2007 | clinicaltrials |
| NCT00525642 | Study of Suitable Schedule of Docetaxel,Anthracycline and Cyclophosphamide in Adjuvant Therapy of Beast Cancer | unknown | Phase 2 / Phase 3 | 603 | Fudan UniversityOTHER | 1 | Sep 6, 2007 | clinicaltrials |
| NCT00192062 | A Trial of Gemcitabine Combined With Vinorelbine as First Line Chemotherapy for Metastatic Breast Cancer | completed | Phase 2 | 80 | Eli Lilly and CompanyINDUSTRY | 1 | Aug 31, 2007 | clinicaltrials |
| NCT00155259 | Docetaxel, Cisplatin and Capecitabine as Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer | completed | Phase 2 | 47 | National Taiwan University HospitalOTHER | 1 | Jul 25, 2007 | clinicaltrials |
| NCT00065533 | Pemetrexed as First Line Chemotherapy for Advanced Breast Cancer | completed | Phase 2 | 92 | Eli Lilly and CompanyINDUSTRY | 6 | Jun 22, 2007 | clinicaltrials |
| NCT00295100 | Tamoxifen-MRI Study | completed | Phase 2 | 78 | University of PennsylvaniaOTHER | 2 | Jun 21, 2007 | clinicaltrials |
| NCT00034827 | A Multicenter Phase 2 Study of CI-1040 in Patients With Advanced Nonsmall-Cell Lung, Breast, Colon and Pancreatic Cancer | completed | Phase 2 | 172 | PfizerINDUSTRY | 1 | May 4, 2007 | clinicaltrials |
| NCT00051051 | A Phase II Study of CI-1033 in Treating Patients With Metastatic (Stage IV) Breast Cancer | completed | Phase 2 | 168 | PfizerINDUSTRY | 9 | May 4, 2007 | clinicaltrials |
| NCT00225056 | Phase II Study of Capecitabine and Weekly Docetaxel Followed by Capecitabine Maintenance for Patients With Metastatic Breast Carcinoma | terminated | Phase 2 | 43 | Oncology Specialties, AlabamaOTHER | 1 | Apr 20, 2007 | clinicaltrials |
| NCT00251329 | Docetaxel, Carboplatin, and Capecitabine as Treatment for Patients With Locally Advanced or Inflammatory Breast Cancer Before Surgery | unknown | Phase 2 | 48 | Cancer Research NetworkOTHER | 1 | Apr 4, 2007 | clinicaltrials |
| NCT00450762 | Gemcitabine + Carboplatin in Breast Cancer | completed | Phase 2 | — | Ludwig-Maximilians - University of MunichOTHER | 0 | Mar 22, 2007 | clinicaltrials |
| NCT00415285 | Docetaxel Followed by Capecitabine Versus Concomitant Docetaxel/Capecitabine for Early Stage Breast Cancer | unknown | Phase 2 | 100 | Georgia Center for Oncology Research & EducationOTHER | 1 | Feb 13, 2007 | clinicaltrials |
| NCT00272740 | SAKK - a Trial to Evaluate Antitumor Efficacy of Faslodex® After Aromatase Inhibitor Failure in Advanced Breast Cancer | completed | Phase 2 | 93 | AstraZenecaINDUSTRY | 2 | Feb 9, 2007 | clinicaltrials |
| NCT00072865 | Pemetrexed and Carboplatin in Locally Advanced or Metastatic Breast Cancer | completed | Phase 2 | 50 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 26, 2007 | clinicaltrials |
| NCT00191347 | A Study of Biweekly Pemetrexed and Gemcitabine in Patients With Metastatic Breast Cancer | completed | Phase 2 | 30 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 26, 2007 | clinicaltrials |
| NCT00191672 | A Trial Of Gemcitabine Plus Paclitaxel And Gemcitabine Plus Docetaxel In Metastatic Breast Cancer | completed | Phase 2 | 120 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 26, 2007 | clinicaltrials |
| NCT00280930 | Letrozole in Postmenopausal Women at Increased Risk for Breast Cancer | unknown | Phase 2 | 60 | Dana-Farber Cancer InstituteOTHER | 1 | Jan 19, 2007 | clinicaltrials |
| NCT00123877 | Study of GPX-100 in the Treatment of Metastatic Breast Cancer | terminated | Phase 2 | 40 | Gem PharmaceuticalsINDUSTRY | 2 | Jan 9, 2007 | clinicaltrials |
| NCT00419679 | Use of Hair to Diagnose Breast Cancer | unknown | Phase 1 / Phase 2 | 3,600 | Fermiscan LtdINDUSTRY | 1 | Jan 9, 2007 | clinicaltrials |
| NCT00419900 | Use of Hair to Diagnose the Presence of Breast Cancer | unknown | Phase 1 / Phase 2 | 2,000 | Fermiscan LtdINDUSTRY | 1 | Jan 9, 2007 | clinicaltrials |
| NCT00186511 | Expanding Rural Access: Distance Delivery of Support | completed | Phase 2 | 40 | Stanford UniversityOTHER | 1 | Dec 5, 2006 | clinicaltrials |
| NCT00381368 | Safety and Efficacy Study of Intravenous Loading Dose of Ibandronate in Breast Cancer Patients | unknown | Phase 2 | 60 | University of TurkuOTHER | 1 | Dec 4, 2006 | clinicaltrials |
| NCT00210028 | Study Assessing Efficacy of ZARNESTRA™ Combined With Tamoxifen in Patients With Advanced or Metastatic Breast Cancer | terminated | Phase 2 | 40 | Institut Claudius RegaudOTHER | 1 | Nov 14, 2006 | clinicaltrials |
| NCT00395655 | Hydralazine and Valproate Added to Chemotherapy for Breast Cancer | terminated | Phase 2 | 43 | National Institute of CancerologíaOTHER_GOV | 1 | Nov 3, 2006 | clinicaltrials |
| NCT00390377 | Use of Hair to Diagnose Breast Cancer | unknown | Phase 2 | 240 | Fermiscan LtdINDUSTRY | 1 | Oct 19, 2006 | clinicaltrials |
| NCT00080197 | Study to Evaluate the Efficacy, Safety, and Tolerability of E7070 in Metastatic Breast Cancer Patients | completed | Phase 2 | 250 | Eisai Inc.INDUSTRY | 2 | Oct 11, 2006 | clinicaltrials |
| NCT00383409 | Multivitamins do Not Improve Radiation Therapy Related Fatigue | completed | Phase 2 | 40 | Faculdade de Medicina do ABCOTHER | 1 | Oct 3, 2006 | clinicaltrials |
| NCT00291798 | Neoadjuvant Endocrinotherapy of Breast Cancer (Mamma Carcinoma) With Exemestane | completed | Phase 2 | 98 | Austrian Breast & Colorectal Cancer Study GroupNETWORK | 1 | Sep 19, 2006 | clinicaltrials |
| NCT00010829 | Macrobiotic Diet and Flax Seed: Effects on Estrogens, Phytoestrogens, & Fibrinolytic Factors | completed | Phase 2 | — | National Center for Complementary and Integrative Health (NCCIH)NIH | 1 | Aug 18, 2006 | clinicaltrials |
| NCT00039793 | Massage Therapy for Cancer-Related Fatigue | completed | Phase 2 | 45 | National Center for Complementary and Integrative Health (NCCIH)NIH | 1 | Aug 18, 2006 | clinicaltrials |
| NCT00034489 | A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients With Metastatic Breast Cancer. | completed | Phase 2 | — | Eli Lilly and CompanyINDUSTRY | 1 | Jul 19, 2006 | clinicaltrials |
| NCT00097383 | Study of Alimta and Epirubicin Administered in Patients With Locally Advanced or Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | — | Eli Lilly and CompanyINDUSTRY | 5 | Jul 19, 2006 | clinicaltrials |
| NCT00337064 | Partial Breast Radiation to the Lumpectomy Cavity With IMRT in Elderly Women | unknown | Phase 1 / Phase 2 | 75 | University of VermontOTHER | 1 | Jun 15, 2006 | clinicaltrials |
| NCT00324610 | Tolerance and Pharmacokinetics With Capecitabine 5 Out of 7 Days Regimen | unknown | Phase 1 / Phase 2 | 46 | Association Pour La Recherche des Thérapeutiques Innovantes en CancérologieOTHER | 1 | May 18, 2006 | clinicaltrials |
| NCT00301548 | Perioperative Chemotherapy After Primary Chemotherapy for Locally Advanced Breast Cancer | completed | Phase 2 | 172 | European Institute of OncologyOTHER | 0 | Mar 13, 2006 | clinicaltrials |
| NCT00250874 | Myocet, Docetaxel & Trastuzumab as 1st Line Treatment of Patients With HER-2/Neu Positive Metastatic Breast Cancer | unknown | Phase 2 | 45 | Zeneus PharmaINDUSTRY | 1 | Nov 8, 2005 | clinicaltrials |
| NCT00006433 | Phase I/II Trial of Doxil and Hyperthermia for Breast Cancer Patients With Chest Wall Recurrence or Stage IV Disease With Locally Advanced Breast Cancer | unknown | Phase 2 | — | National Center for Research Resources (NCRR)NIH | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00041808 | Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver | completed | Phase 1 / Phase 2 | 20 | FeRxINDUSTRY | 2 | Jun 24, 2005 | clinicaltrials |
Data updated 23 days agoSource updated Dec 18, 2007source: clinicaltrials